/PRNewswire/ USA News Group - Nearly 10% of the estimated ~1.9 million new cancer cases in the USA will be diagnosed as leukemia, lymphoma and myeloma..
FT. MYERS, FL / ACCESSWIRE / December 10, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced
NeoGenomics to Leverage Thermo Fisher Scientific's Ion Torrent Genexus System in Upcoming Phase 1 Study for Myeloid Cancers pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
NeoGenomics to Leverage Thermo Fisher Scientific's Ion Torrent Genexus System in Upcoming Phase 1 Study for Myeloid Cancers theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
NeoGenomics to Leverage Thermo Fisher Scientific's Ion Torrent Genexus System in Upcoming Phase 1 Study for Myeloid Cancers tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.